JPWO2020097325A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020097325A5 JPWO2020097325A5 JP2021523935A JP2021523935A JPWO2020097325A5 JP WO2020097325 A5 JPWO2020097325 A5 JP WO2020097325A5 JP 2021523935 A JP2021523935 A JP 2021523935A JP 2021523935 A JP2021523935 A JP 2021523935A JP WO2020097325 A5 JPWO2020097325 A5 JP WO2020097325A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- modified
- polypeptide
- cancer
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 150000001540 azides Chemical class 0.000 claims description 3
- 150000002668 lysine derivatives Chemical class 0.000 claims description 3
- 102000003814 Interleukin-10 Human genes 0.000 claims 17
- 108090000174 Interleukin-10 Proteins 0.000 claims 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 4
- 230000001268 conjugating effect Effects 0.000 claims 4
- 229940076144 interleukin-10 Drugs 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 229920003169 water-soluble polymer Polymers 0.000 claims 3
- RPLCQQYRZLXMKL-ZETCQYMHSA-N (2s)-2-amino-6-(2-azidoethoxycarbonylamino)hexanoic acid Chemical compound OC(=O)[C@@H](N)CCCCNC(=O)OCCN=[N+]=[N-] RPLCQQYRZLXMKL-ZETCQYMHSA-N 0.000 claims 2
- 102000004551 Interleukin-10 Receptors Human genes 0.000 claims 2
- 108010017550 Interleukin-10 Receptors Proteins 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000000710 homodimer Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010005949 Bone cancer Diseases 0.000 claims 1
- 208000018084 Bone neoplasm Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 208000024519 eye neoplasm Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000008106 ocular cancer Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000012385 systemic delivery Methods 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- -1 methoxy, acetyl Chemical group 0.000 description 1
Description
いくつかの例では、非天然アミノ酸は、リジン誘導体を含有するベンゾフェノン、ケトン、ヨウ化物、メトキシ、アセチル、ベンゾイル、またはアジドである。
In some examples, the unnatural amino acid is a benzophenone, ketone, iodide, methoxy, acetyl, benzoyl, or azide containing lysine derivative .
Claims (21)
該アミノ酸配列は配列番号1のアミノ酸33~158と99%同一であり、該少なくとも1つの非天然アミノ酸はリシン誘導体を含むアジドであるポリペプチドである、前記核酸分子。 1. A nucleic acid molecule encoding a polypeptide comprising an amino acid sequence comprising at least one unnatural amino acid ,
The nucleic acid molecule is a polypeptide whose amino acid sequence is 99% identical to amino acids 33-158 of SEQ ID NO:1, and wherein the at least one unnatural amino acid is an azide containing lysine derivative .
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862757690P | 2018-11-08 | 2018-11-08 | |
US62/757,690 | 2018-11-08 | ||
US201962911036P | 2019-10-04 | 2019-10-04 | |
US62/911,036 | 2019-10-04 | ||
PCT/US2019/060261 WO2020097325A1 (en) | 2018-11-08 | 2019-11-07 | Interleukin 10 conjugates and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022506531A JP2022506531A (en) | 2022-01-17 |
JPWO2020097325A5 true JPWO2020097325A5 (en) | 2024-05-16 |
Family
ID=70612119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021523935A Pending JP2022506531A (en) | 2018-11-08 | 2019-11-07 | Interleukin 10 conjugate and its use |
Country Status (16)
Country | Link |
---|---|
US (1) | US20210338829A1 (en) |
EP (1) | EP3876973A4 (en) |
JP (1) | JP2022506531A (en) |
KR (1) | KR20210091170A (en) |
CN (1) | CN113260374A (en) |
AU (1) | AU2019376076A1 (en) |
BR (1) | BR112021005401A2 (en) |
CA (1) | CA3117572A1 (en) |
CO (1) | CO2021003530A2 (en) |
IL (1) | IL282736A (en) |
MA (1) | MA54195A (en) |
MX (1) | MX2021005293A (en) |
PH (1) | PH12021550611A1 (en) |
SG (1) | SG11202102930YA (en) |
TW (1) | TW202031284A (en) |
WO (1) | WO2020097325A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2020001336A (en) | 2017-08-03 | 2020-08-20 | Synthorx Inc | Cytokine conjugates for the treatment of autoimmune diseases. |
EP3758729A4 (en) | 2018-02-26 | 2021-11-17 | Synthorx, Inc. | Il-15 conjugates and uses thereof |
MA54952A (en) | 2019-02-06 | 2022-05-11 | Synthorx Inc | IL-2 CONJUGATES AND METHODS OF USING THE SAME |
CH716227B1 (en) * | 2020-04-16 | 2020-11-30 | Contrad Swiss Sa | Gel composition for topical application for the reduction of local inflammation. |
US20240010695A1 (en) * | 2020-12-09 | 2024-01-11 | Asher Biotherapeutics, Inc. | Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell function |
CN112618699A (en) * | 2020-12-31 | 2021-04-09 | 深圳先进技术研究院 | Reagent capable of providing interleukin 10 with effective treatment amount and antitumor application thereof |
KR20240024235A (en) * | 2021-07-29 | 2024-02-23 | 노보코덱스 바이오파마슈티컬즈 컴퍼니 리미티드 | Non-natural amino acids and uses thereof, recombinant proteins containing them, and recombinant protein conjugates |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003280315A1 (en) * | 2002-11-14 | 2004-06-03 | Maxygen, Inc. | Conjugates of interleukin-10 and polymers |
EP1610825A2 (en) * | 2003-03-31 | 2006-01-04 | Xencor, Inc. | Methods for rational pegylation of proteins |
EP2820033A4 (en) * | 2012-02-29 | 2015-01-07 | Ambrx Inc | Interleukin-10 polypeptide conjugates and their uses |
US9823255B2 (en) * | 2013-06-17 | 2017-11-21 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
WO2017035232A1 (en) * | 2015-08-25 | 2017-03-02 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
JP2022512746A (en) * | 2018-10-19 | 2022-02-07 | アンブルックス,インコーポレイテッド | Interleukin-10 polypeptide complex, its dimer, and their use |
-
2019
- 2019-11-07 WO PCT/US2019/060261 patent/WO2020097325A1/en active Application Filing
- 2019-11-07 CN CN201980088002.1A patent/CN113260374A/en active Pending
- 2019-11-07 SG SG11202102930YA patent/SG11202102930YA/en unknown
- 2019-11-07 CA CA3117572A patent/CA3117572A1/en active Pending
- 2019-11-07 BR BR112021005401-4A patent/BR112021005401A2/en unknown
- 2019-11-07 MX MX2021005293A patent/MX2021005293A/en unknown
- 2019-11-07 TW TW108140531A patent/TW202031284A/en unknown
- 2019-11-07 AU AU2019376076A patent/AU2019376076A1/en active Pending
- 2019-11-07 EP EP19882876.6A patent/EP3876973A4/en active Pending
- 2019-11-07 MA MA054195A patent/MA54195A/en unknown
- 2019-11-07 KR KR1020217014864A patent/KR20210091170A/en unknown
- 2019-11-07 JP JP2021523935A patent/JP2022506531A/en active Pending
-
2021
- 2021-03-18 PH PH12021550611A patent/PH12021550611A1/en unknown
- 2021-03-18 CO CONC2021/0003530A patent/CO2021003530A2/en unknown
- 2021-04-28 IL IL282736A patent/IL282736A/en unknown
- 2021-05-06 US US17/313,579 patent/US20210338829A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210155665A1 (en) | Method for preparing interleukin-2 or interleukin-2 analogues | |
Wan et al. | Peptide‐Decorated Dendrimers and Their Bioapplications | |
CN100379760C (en) | Peptides and compounds that bind to receptor | |
JP2018138588A (en) | Novel linker, preparation method, and application thereof | |
US10407468B2 (en) | Methods for synthesizing α4β7 peptide antagonists | |
ES2229355T3 (en) | PROCEDURE FOR THE MANUFACTURE OF MEDICINAL COMPLEXES. | |
US6733755B2 (en) | Ligand for vascular endothelial growth factor receptor | |
US20110312877A1 (en) | Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use | |
JP2012158598A (en) | Novel poly(ethylene glycol) modified compound and use thereof | |
JP2000512633A (en) | Cyclic polypeptides containing thioether bonds and methods for their preparation | |
JP2001512739A (en) | Linear peptides derived from antibiotic peptides, their preparation and their use in mediating active substances | |
US9415114B2 (en) | Conformations of divergent peptides with mineral binding affinity | |
WO2021167107A1 (en) | Human transferrin receptor binding peptide | |
Selvaraj et al. | Expedient on-resin modification of a peptide C-terminus through a benzotriazole linker | |
EP2185588B1 (en) | Synthetic pulmonary surfactant peptides | |
JPWO2020097325A5 (en) | ||
US20170246311A1 (en) | Peptides for binding alternatively activated macrophages | |
JPH11515032A (en) | Peptide derivatives of dolastatin 15 and uses thereof | |
RU2021115678A (en) | INTERLEUKIN 10 CONJUGATES AND THEIR APPLICATIONS | |
JP2003534387A (en) | Tumor activating prodrug compounds and methods for their production and use | |
JP3939354B2 (en) | Antitumor peptide | |
Pineda-Castañeda et al. | Designing Short Peptides: A Sisyphean Task? | |
ES2930177T3 (en) | Optimized Procedure for Peptide-Dimeric Phospholipid Conjugate | |
TWI772159B (en) | Method of synthesizing dendrimeric amphiphile | |
JP2008200011A (en) | Peptide with intracellular transferability, pharmaceutical composition containing the same and method for using the same |